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Abstract
Genetic studies of rare diseases can identify genes of unknown function that strongly impact human physiology. Prolyl
endopeptidase-like (PREPL) is an uncharacterized member of the prolyl peptidase family that was discovered because of its
deletion in humans with hypotonia-cystinuria syndrome (HCS). HCS is characterized by a number of physiological changes
including diminished growth and neonatal hypotonia or low muscle tone. HCS patients have deletions in other genes as
well, making it difficult to tease apart the specific role of PREPL. Here, we develop a PREPL null (PREPL2/2) mouse model to
address the physiological role of this enzyme. Deletion of exon 11 from the Prepl gene, which encodes key catalytic amino
acids, leads to a loss of PREPL protein as well as lower Prepl mRNA levels. PREPL2/2 mice have a pronounced growth
phenotype, being significantly shorter and lighter than their wild type (PREPL+/+) counterparts. A righting assay revealed
that PREPL2/2 pups took significantly longer than PREPL+/+ pups to right themselves when placed on their backs. This
deficit indicates that PREPL2/2 mice suffer from neonatal hypotonia. According to these results, PREPL regulates growth
and neonatal hypotonia in mice, which supports the idea that PREPL causes diminished growth and neonatal hypotonia in
humans with HCS. These animals provide a valuable asset in deciphering the underlying biochemical, cellular and
physiological pathways that link PREPL to HCS, and this may eventually lead to new insights in the treatment of this disease.
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Introduction
Interest in the prolyl endopeptidase-like gene (PREPL) was
sparked by the discovery that this gene associated with 2p21
deletion syndrome [1,2] and also with hypotonia-cystinuria
syndrome (HCS) [3–5]. HCS presents clinically as decreased
muscle tone (hypotonia) as well as excess cystine in the urine
(cystinuria), but other symptoms such as diminished growth and
mild mental retardation are also associated with HCS. Invariably,
HCS is associated the deletion of other genes besides PREPL.
Often a PREPL neighboring gene called solute carrier family 3
(amino acid transporter heavy chain) member 1 (SLC3A1) is also
missing. In addition, in some atypical HCS cases, PREPL and
SLC3A1 are deleted with another gene, calmodulin-lysine N-
methyltransferase (CAMKMT or C2ORF34) [6]. Isolated deletions
of SLC3A1, which is highly expressed in the kidney [7], are known
to cause cystinuria [8], suggesting that PREPL is accountable for
the other symptoms associated with HCS. More specifically,
PREPL deletion is thought to cause neonatal hypotonia [3] and
impaired growth [9], but this has yet to be confirmed by a deletion
of PREPL alone.
PREPL is the most recently discovered member of the prolyl
peptidase family. The most well-known prolyl peptidase, dipepti-
dyl peptidase 4 (DPP4), , regulates postprandial insulin levels
through its degradation of the incretin glucagon-like peptide 1
(GLP-1) [10]. DPP4 is also a target for a new class of anti-diabetic
drugs [11], attracting attention to this enzyme family and
highlighting the importance of these proteins in physiology.
Unlike the other prolyl peptidases, PREPL has not shown any
peptide proteolysis in vitro, though it will cleave small molecule
esters and fluorophosphonates [9,12,13]. Currently, PREPL is not
thought to function as a peptidase; instead recent work suggests
that PREPL utilizes protein-protein interactions to affect cell
biology [14–16].
Genetic studies of diseases have provided a wealth of insight into
molecular pathways underlying human physiology [17–20], and in
some cases these insights lead to the development of novel
therapeutics [21]. For instance, the investigation of hypercholes-
terolemia led to important insights into the regulation of
cholesterol that has been valuable in the treatment of coronary
heart disease [18]. Elucidating PREPL function may reveal new
molecular pathways related to the regulation of muscle tone and
impaired growth. Here, we develop a transgenic mouse that lacks
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PREPL to characterize the physiological function of PREPL. This
model will allow us to conclusively test the hypothesis that PREPL
is responsible for growth regulation and hypotonia in vivo, and will
provide a valuable model that will eventually be used to elucidate
the biochemical, cellular and physiological functions of PREPL.
Results and Discussion
Generation of Mice Lacking Prepl
Generation of a mouse model began with the design and
production of a targeting construct that was used to replace part of
the Prepl-coding region of the genome in embryonic stem cells by
homologous recombination. In this construct, exon 11 of the Prepl
gene, which contains the catalytic serine nucleophile, was placed
between two Cre recombinase recognition sites (LoxP sites) [22]
(Fig. 1A). This would allow for the tissue- or age-specific removal
of PREPL catalytic activity, if necessary. The construct also
included additional restriction sites to enable the identification of
successful homologous recombination events in ES cells and the
germ line transmission of this construct in chimeric mice by
Southern blot (Fig. 1, Fig. S1 in File S1). This approach
circumvents any issues that might result from targeting an early
exon, such as production of a truncated PREPL enzyme retaining
catalytic activity. A Neomycin (NEO) selection marker was also
included and flanked by flippase recognition target (Frt) sites [23],
which allows removal of this cassette as well. The construct was
prepared and fully sequenced to ensure accuracy and then
introduced into ES cells followed by a positive selection with
neomycin to identify clones that had incorporated the construct.
Individual clones were then analyzed by Southern blot to identify
ES cells that had undergone homologous recombination to
incorporate the construct in the correct manner (Fig. S2 in File
S1).
After karyotyping, ES cells were injected into blastocysts and
implanted into mice. The resulting offspring were high percentage
chimeras and germ line transmission of the new allele, Prepltm1Sagh,
was observed when breeding these animals to C57BL/6J mice
(Fig. 1A), as determined by Southern blot analysis of the offspring
(Fig. 1A and 1B). After excision of the Neomycin marker, these
animals were crossed with mice expressing Cre recombinase to
also excise exon 11 from Prepl (Fig. 1C), thus generating
Prepltm1.2Sagh/+ mice, referred to from here on as PREPL2/+ mice.
Removal of exon 11 on one allele in these offspring was confirmed
by PCR. In turn, PREPL2/+ mice were bred to each other to
produce PREPL2/2 and PREPL+/+ mice to carry out the
experiments in this manuscript. A genotyping strategy was devised
to distinguish between all possible genotypes in these mice, and
detected the presence and absence of the construct as well as the
presence and absence of exon 11 (Fig. 1D, Fig. S3 in File S1).
Next, we wanted to ensure that PREPL was in fact completely
absent in this mouse. A western blot confirmed the absence of full
length PREPL protein in PREPL2/2 mice (Fig. 2A). Further,
reverse-transcription-polymerase chain reaction (RT-PCR) exper-
iments demonstrated that Prepl mRNA is considerably less
abundant in PREPL2/2 mice (Fig. 2B). The fact that removal
of exon 11 resulted in lower levels of Prepl mRNA suggested that it
was being degraded and analysis of the Prepl mRNA sequence in
the absence of exon 11 showed that it will contain additional stop
codons (Fig. S4 in File S1). To protect against the generation of
truncated proteins, cells utilize a process called nonsense-mediated
decay (NMD) to remove mRNAs with premature stop codons
[24], and it is likely that NMD is responsible for the lower levels of
Prepl mRNA observed in the PREPL2/2 mice.
Prepl Regulates Body Size
Having validated that the PREPL2/2 mice lack PREPL
protein, we wanted to identify any phenotypes associated with
the loss of this protein, including changes that are similar to the
symptoms attributed to PREPL deletion in HCS. The most overt
difference was that PREPL2/2 animals were significantly smaller
than their PREPL+/+ counterparts (Fig. 3). Indeed, measurements
of female and male mice at one month of age revealed that
PREPL2/2 mice had impaired growth, with shorter body lengths
compared to PREPL+/+ mice (Fig. 3A). To quantify these
differences in body size, we obtained growth curves for male
and female PREPL2/2 and PREPL+/+ mice from birth.
PREPL2/2 mice of both sexes exhibited lower weights than their
PREPL+/+ counterparts beginning around day 20 and this trend
continued and increased up until the mice were 40 days old
(Fig. 3B). Taking the area under the curve (AUC) for the
respective growth curves also resulted in a significant difference for
these animals between 1–40 days (Fig. S5 in File S1).
Humans with HCS frequently start exhibiting hyperphagia and
rapid weight gain in late childhood, a phenotype suspected to be
caused by PREPL deletion [3,25]. To assess whether a similar
phenotype was present in these animals and to determine how the
weights of these mice developed over a longer time, we therefore
performed more extended growth curve analysis of these animals,
continuing out to 21 weeks of age (Fig. S6 in File S1). From this
more extended growth curve, it was apparent that both male and
female PREPL2/2 mice continued to lag behind their PREPL+/+
counterparts in weight later in life as well, with final weights of
PREPL2/2 animals significantly lower than those of PREPL+/+
controls. This indicates that the hyperphagia observed in HCS
patients is not phenocopied in the PREPL2/2 mice, but rather
that the differences in size which first appeared at a few weeks of
age remained throughout the lifetime of these animals (Fig. S6 in
File S1).
Neonatal Hypotonia Associated with A Loss of Prepl
Human patients with HCS typically exhibit neonatal hypoto-
nia–decreased muscle tone [3]. In humans this is manifested by
difficulties in feeding at a young age and resolves as the patients
age. To determine whether neonatal hypotonia is due to PREPL
deficiency, we examined these mice in two different assays. First,
we performed a grip strength assay, which measures the maximum
force applied by a mouse grabbing a bar with its forelimbs and is
used to infer muscle strength and also hypotonia in adult mice
[26,27]. Grip strength assays on six-month old female mice found
no significant difference in grip strength between PREPL+/+ and
PREPL2/2 mice when normalized for body weight (Fig. 4A),
suggesting that these animals could generate similar force per
gram of mouse. Because of their smaller size, the PREPL2/2 mice
were not as strong on an absolute scale (Fig. S7 in File S1).
To analyze strength and possible hypotonia at an earlier age,
resembling the neonatal stage in humans, we selected a surface-
righting test [28,29] on five-day old pups. In this assay, mice are
placed on their backs on a flat surface and the latency before they
are able to ‘right’ themselves is measured. Hypotonic pups would
be expected to take longer before being able to assume the normal
upright position with all four paws on the ground than pups with
normal muscle tone. Thus, this assay provides a measure of
neonatal hypotonia. A surface-righting assay on PREPL+/+ and
PREPL2/2 mice revealed a clear difference between these
animals, with PREPL2/2 pups taking over twice as long to right
themselves as PREPL+/+ mice (Fig. 4B). This data supports the
idea that PREPL2/2 pups have neonatal hypotonia, and
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Figure 1. Construct design and validation. A) The genome region around PREPL’s exon 11 was used to design a targeting vector for
homologous recombination. This vector included a neomycin (NEO) cassette for positive selection, Frt sites flanking the NEO cassette, LoxP sites
flanking exon 11, a HindIII restriction site for 59-Southern blots, and an NdeI site for 39-Southern blots. Homologous recombination in ES cells
generated cells carrying recombinant genomic DNA, which according to standard nomenclature (Genetm#Labcode) is referred to as Prepltm1Sagh. These
ES cells were then used to generate chimeric mice designated Prepl+/tm1Sagh. B) The germ line transmission of the Prepltm1Sagh allele to the offspring
from chimera-C57BL/6J crosses was confirmed by Southern blots of tail genomic DNA. Restriction digests of the genomic DNA with HindIII (59) or
NdeI (39), followed by probing with a 59 or 39 specific probe generated a single band for Prepl+/+ (left lane), whereas an additional, lower molecular
weight band is generated in mice carrying the Prepltm1Sagh allele (right lane). C) Prepl+/tm1Sagh were then crossed with mice expressing Flp
recombinase to produce Prepl+/tm1.1Sagh mice (middle) lacking the NEO cassette, and finally crossed with mice ubiquitously expressing Cre
recombinase, resulting in Prepl+/tm1.2Sagh mice (bottom) which lack exon 11. We refer to these Prepl+/tm1.2Sagh mice as PREPL+/2 mice. D)
Representative PCR genotyping results for PREPL+/+, PREPL2/2 and PREPL+/2 mice. Using this strategy, one can easily distinguish these three
genotypes as well as other possible genotypes, such as the Prepltm1.1Sagh allele.
doi:10.1371/journal.pone.0089160.g001
Figure 2. Homozygous PREPL2/2 mice lack PREPL and have diminished Prepl mRNA levels. A) Western blot for PREPL in the spinal cords
of PREPL+/+ and PREPL2/2 mice. Recombinant PREPL (lane 1) is used as a positive control to test the polyclonal antibody used to in this blot. Analysis
of spinal cord samples from PREPL2/2 (lanes 2–4) and PREPL+/+ (lanes 5–7) demonstrate the PREPL2/2mice lack full-length PREPL protein. Removal of
exon 11 could result in a truncated PREPL protein, but no evidence of a shorter protein is evident in the western blot of PREPL2/2 samples (lanes
2–4). B) Analysis of Prepl mRNA by qPCR in mouse liver reveals that there is substantially less Prepl transcript in the liver of PREPL2/2 mice when
compared to PREPL+/+, indicating that removal of exon 11 also impacts mRNA levels. (Error bars depict SEM. Statistical significance calculated by a
Student’s t-test, p-value,0.05, *, N = 4).
doi:10.1371/journal.pone.0089160.g002
PREPL Regulates Body Size and Strength
PLOS ONE | www.plosone.org 3 February 2014 | Volume 9 | Issue 2 | e89160
highlights a role for PREPL in the developing musculoskeletal
system.
Conclusion
Based on interest in the prolyl peptidase family and the
underlying causes of HCS, we have generated a knockout model
to study the physiological role of PREPL. An important goal in this
study was to test the hypothesis that PREPL affects growth and
muscle tone, as suggested by human genetics of individuals with
HCS and 2p21 deletion syndrome [1,2,12]. In doing so, these
experiments would also reveal whether PREPL impacts similar
physiology in mice and humans, making these animals a valuable
scientific model. The most overt phenotype in PREPL2/2 mice
was their reduced body size relative to their PREPL+/+ siblings.
Growth curves quantified this effect, demonstrating that a
difference emerged at approximately three weeks and continued
throughout the remainder of the animals’ lives. Patients with HCS
suffer from stunted growth and this mouse model demonstrates
that PREPL does in fact have a role in the regulation of body size
and that this function is conserved from mouse to man.
The growth curves observed for the PREPL2/2 mice are
strikingly similar to those seen for mouse models with growth
hormone defects, such as growth hormone receptor knockout mice
[30], suggesting that diminished growth hormone signaling may
underlie this phenotype. This theory is supported by the fact that
HCS patients are known to have defects in growth hormone
signaling and this has been proposed to be responsible for their
stunted growth. With these PREPL2/2 mice in hand, it will now
be possible to eventually test this hypothesis in an experimental
model.
Figure 3. PREPL2/2 mice have diminished growth rates and are smaller than PREPL+/+ animals. A) Body lengths of one-month old
PREPL2/2 and PREPL+/+ mice were compared. Both female and male PREPL2/2 mice are visibly smaller than PREPL+/+ mice. B) Female and male mice
of both genotypes were weighed every day for the first forty days after birth to obtain growth curves. Female PREPL2/2 mice begin to gain less
weight than PREPL+/+ mice at about three weeks old, with the data being statistically significant at day 26, while male PREPL2/2 mice show
significantly less weight gain than PREPL+/+ mice from postnatal day 21. (Error bars show SEM and significance calculated using the Holm-Sidak
method to correct for multiple comparisons, alpha = 5%, each row was analyzed individually, without assuming a consistent SD).
doi:10.1371/journal.pone.0089160.g003
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A surface-righting assay revealed that five-day old PREPL2/2
mice have difficulty righting themselves, indicating that these pups
likely suffer from hypotonia. In humans with HCS, hypotonia is
usually resolved by adulthood. While grip strength is not a direct
measure of hypotonia, adult PREPL2/2 mice have a similar
strength-to-weight ratio as PREPL+/+ mice, suggesting that any
muscular issues have resolved by this time. In conclusion, the data
from this animal model support the hypothesis that loss of PREPL
is responsible for impaired growth and hypotonia in mammals,
which provides additional evidence for its predicted role in HCS
and 2p21 deletion syndrome. With this mouse model in hand, the
molecular, cellular, and physiological mechanisms linking PREPL
to growth and hypotonia can be studied in detail, which promises
to reveal new pathways and mechanisms for regulating these
important physiological processes.
Materials and Methods
Cloning of the Homologous Recombination Construct
The homologous recombination construct was cloned from a
bacmid containing the C57BL/6J DNA sequence surrounding the
Prepl gene (from the BAC library RPCI-23 from Children’s
Hospital Oakland Research Institute) and from the vector LoxP-
Neo2 (a kind gift from Akio Kobayashi/Andy McMahon) which
contains a Neomycin resistance gene under the control of a PGK
promoter. The relevant portions of the genome and of the
neomycin resistance marker were amplified and necessary
restriction sites inserted using the following primers. 59 Arm
FWD: AAA ACT CGA GGC GGC CGC AAA ATC ATT CAG
AGC ATC CGC GTG AGG, 59 Arm REV: AAA AGG TAC
CAC AAC CCC AAA AGC TGA TTC, Exon 11 FWD: AAA
AGG TAC CAA GCT TAT AAC TTC GTA TAG CAT ACA
TTA TAC GAA GTT ATT TGG TTT GGT TCC TAC GAT,
Exon 11 REV: AAA AGG ATC CTT AAT TAA CAG GAT
GCT GTC ACA TGG AC, 39 Arm FWD: AAA AGG ATC
CGG CGC GCC CAT ATG CCC AGC TGC ATC TTA TTC
TG, 39 Arm REV: AAA AGT CGA CCG GCT GGC AAG
GGT GTC ATG. The 59 Arm was cloned into the vector
pSL1180DT Vector (a kind gift from Mychelle Neptune/James
Horner) using KpnI and XhoI restriction sites. Correct incorpo-
ration was confirmed and the exon 11 region was cloned into this
vector using BamHI and KpnI restriction sites. The 39 Arm was
the inserted using BamHI and SalI restriction sites and finally the
PGK Neo cassette was incorporated using PacI and AscI
restriction sites. Analytical restriction digests confirmed correct
incorporation of the four sequence elements and the finished
construct was completely sequenced to ensure that the sequence
was correct and no mutations had been introduced (see appendix
for complete sequence).
Electroporation
An endotoxin-free maxiprep-kit (Qiagen) was used to purify
sufficient amounts of endotoxin-free construct. The plasmid
containing the construct was then linearized with the NotI
restriction enzyme and ethanol precipitated. After washing the
pellet three times with ethanol, the DNA was electroporated into
the V6.5 F1 129SvJae- C57BL/6J mouse embryonic stem (ES) cell
line [31], a kind gift from the Jaenisch Lab, and transformed cells
were selected using standard techniques.
Isolation of DNA for Southern blots
To prepare DNA from ES cells, 0.5 mL of PK solution (10 mM
Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5% SDS, 0.2 mg/
mL Proteinase K) was added to each well in a 48-well plate and
incubated at 37uC for 1–4 hours. This solution was transferred to
a microcentrifuge tube and extracted first with phenol:chloroform:
isoamyl alcohol (49.5:49.5:1) and then with chloroform:isoamyl
alcohol (49:1). One milliliter of isopropanol is added to precipitate
DNA, and the tubes are centrifuged for 5 minutes at 16,000 g in a
microcentrifuge. The pellet is washed with 70% ethanol, which is
then carefully and completely removed. The DNA is air dried for
twenty minutes, whereupon it is redissolved in 100 mL of water
with 0.2 mg/mL RNAse A. To prepare DNA from mouse tails,
we adapted a protocol from http://www.cellmigration.org/
resource/komouse/protocols/mouse_management_feb06.pdf.
Briefly, 250 mL of lysis buffer (100 mM Tris (pH 8.8), 50 mM
NaCl, 5 mM EDTA, 0.2% SDS, 0.2 mg/mL Proteinase K) was
added to each tail and samples were incubated at 55uC overnight.
Tubes were briefly centrifuged and liquid transferred to a fresh
tube. Isopropanol (250 mL) was added to precipitate the DNA.
The samples were inverted to mix and centrifuged at 16,000 g for
10 minutes. The supernatant was removed and the DNA was
allowed to air dry for 10 minutes, after which it was suspended in
water.
Southern Blots
Ten micrograms of genomic DNA (for isolation, see section
‘‘Isolation of DNA for Southern Blots’’) was digested with the
appropriate restriction enzyme overnight (for 59 Southern blots,
HindIII was used, for 39 Southern blots, NdeI was used). Digested
samples were run on a 0.8% agarose TAE gel at 40 V for
3–4 hours and an image of the gel obtained. The gel was rinsed in
distilled water on a rocker at room temperature for 15 minutes
and depurinated by rocking in 0.25 M HCl for 30 minutes at
room temperature. The dye colors should change in this process.
The gel was then rinsed in distilled water on the rocker for
5–10 minutes and equilibrated in transfer buffer (0.4 M NaOH)
until the dye colors to changed back to their original colors. The
gel stack for transfer was set up according to the Whatman,
Schleicher and Schuell Turboblotter Rapid Downward Transfer
Systems manual (Whatman). The Amersham HyBond-XL mem-
brane was used for this transfer and was presoaked in water for five
minutes. The transfer was allowed to proceed overnight and an
Figure 4. Grip strength and righting assay to assess hypotonia
in PREPL2/2 mice. A) Six month old female mice had no difference in
grip strength between genotypes when normalized to their respective
body weights. B) A comparison of pups of both genders and genotypes
in a righting assay. In this experiment, mice are placed on their backs
and the time it takes for them to right themselves is measured. At day 5,
PREPL2/2 pups are much slower at righting themselves than PREPL+/+
mice. (Error bars show SEM and Statistical significance calculated by a
Student’s t-test, p-value,0.05, *, N = 4–5 for grip strength and
N=13–14 for the righting assay).
doi:10.1371/journal.pone.0089160.g004
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efficient transfer was assessed by determining if the blotting paper
at the bottom of the stack was moist. With the gel still in place, the
membrane was cut into sections along the gel wells and labeled
with a pencil. The membrane was neutralized by rocking at room
temperature in 20 mM Tris (pH 7), 26 SPPE for 15 minutes or
more. Ten milliliters of pre-melted PreHyb solution (Clontech) was
added to hybridization tubes and membranes were placed in these
tubes with the DNA side pointing toward the center of tube.
Membranes were rotated for 2–3 hours at 65uC in a hybridization
oven while generating the probe. The 59 probe was designed to
bind 59 of the construct, outside of the homology arm, and was
generated using the following primers: 59 Southern Probe
FWD: CCT CCA TCT CTT GGC TTT G 59 Southern Probe
REV: GCAGT TAT TAT TCC AGG GC. The 39 probe was
designed to bind 39 of the construct, outside of the homology arm,
and was generated using the following primers: 39 Southern
Probe FWD: GCA GTT GTT GCC ATT GTT ACT GTA
GTT C and 39 Southern Probe REV: CCA TTT CAT GAT
ACC TAG TCA TTT CAT GAT. The probes were prepared for
labeling by placing 100–150 ng of the described PCR products in
a final volume of 23 ul water. The DNA was denatured by boiling
for 5 minutes, then cooled immediately on ice. Two microliters
each of dATP, dGTP and dTTP, as well as 15 ul Random Primer
Buffer Mixture (all from Invitrogen Random Primer Labeling Kit)
were added to the probe. Five microliters of P32-dCTP (,50 uCi)
and 1 ul of Klenow fragment (New England Biolabs) were added
and mixed by tapping, then incubated at room temperature for
2 hours. The probe was purified using a NICK column (GE
Healthcare). The column was rinsed with Tris-EDTA (TE) and
several columns of TE were passed through the column to
equilibrate it. Sample (50 ml probe+50 ml TE, mixed) was added to
the column, followed by 400 ml of TE. The eluate was discarded.
Further TE (26200 ul) was added to the column and eluates were
collected. A scintillation counter was used to determine the counts
per minute (cpm) for 1 ul of each eluate fraction. An appropriate
volume of probe (corresponding to 35*106 cpm) was removed and
denatured by boiling for 5 minutes, then immediately cooled on
ice. The PreHyb solution in the hybridization tubes was replaced
with fresh PreHyb solution and the denatured probe added and
rotated in a hybridization oven overnight. The next day, while still
rotating in hybridization oven, the probe-containing PreHyb
solution was discarded and the membrane washed 2620 min with
26SSC with 0.1% SDS, then 2620 min with 16SSC with 0.1%
SDS (,10 mL solution per Hyb tube). Membranes were wrapped
in Saranwrap, using water as necessary to keep flat, and wrapped
membranes were placed facing a phosphor storage screen in a
phosphor imaging cassette. The cassette was let sit undisturbed for
,7 days, then scanned on a phosphor imager (Storm 860, GE).
Generation of Chimeras, Confirmation of Germ line
Transmission and Removal of the Neomycin Resistance
Marker and Prepl’s Exon 11
Blastocyst injections were carried out with two independent
targeted clones to generate chimeras. High-percentage chimeras
were bred to C57BL/6J mice and some of the offspring from these
crosses were confirmed to harbor the construct by performing a
Southern blot on DNA obtained from their tails. These
Prepltm1Sagh/Prepl+ mice were then crossed with Pgk-Flpe mice on
a Swiss Webster mixed background (a kind gift from the Andy
McMahon lab) to obtain Prepltm1.1Sagh/Prepl+ mice. These mice,
which contain the homologous recombination construct including
Prepl’s exon 11, were then crossed with B6.FVB-Tg(Eiia-
Cre)C5379Lmgd/J (stock # 003724, The Jackson Laboratory)
to excise Prepl’s exon 11 and produce Prepltm1.2Sagh/Prepl+ mice (in
the text referred to as Prepl+/2 mice.
PCR Genotyping
To confirm that the Neomycin marker had been excised, PCR
was performed with the following primers: NEO FWD: CCC
ACT GTC CTT TCC TAA TAA AAT GAG G, NEO REV:
AAG ACT GTA GGG CAT TTC CGG AAC TGA. In mice
were the neomycin cassette was present, this PCR produced a
band, while in the absence of the neomycin resistance gene, no
band was produced. Once confirmation of the removal of the
neomycin resistance gene had been confirmed, genotyping was
routinely performed using four different set of primers, to
distinguish between all possible genotypes. The four sets were:
PRESENCE OF EXON 11 FWD: GGTGGTGGCGAGC-
TAGGTCT, PRESENCE OF EXON REV: AGAGAGACC-
TATTCCCTATGTC, ABSENCE OF EXON 11 FWD:
ACCCCTTTACCCTGTTTGTGTA, ABSENCE OF EXON
11 REV: AGAGAGACCTATTCCCTATGTC, PRESENCE
OF CONSTRUCT FWD: TCTAGAAAGTATAGGAACTT-
CACCG, PRESENCE OF CONSTRUCT REV: AAGACTG-
TAGGGCATTTCCGGAACTGA, ABSENCE OF CON-
STRUCT FWD: TGCCTTCAGACACCATGCTCT,
ABSENCE OF CONSTRUCT REV: AGCTGGGCAG-
GATGCTG. DNA for genotyping was isolated from tail snips
using the DNeasy Blood and Tissue Kit (Qiagen).
Mouse Colony Maintenance
Animals were kept on a 12-h light, 12-hour dark schedule and
fed ad libitum. Mice were bred either in static breeding pairs, in
duos or trios. Pups were weaned at P21. Tattooing (ATS-3
General Rodent Tattoo System, AIMS) and genotyping was
performed at week 5–8. All animal care and use procedures were
in strict accordance with the standing committee on the use of
animals in research and teaching at Harvard University and the
National Institutes of Health guidelines for the humane treatment
of laboratory animals. All protocols were approved by the Harvard
IACUC. If during the course of these experiments mice that
showed any signs of illness, including decreased activity, hunched
posture, poor/decreased grooming, poor response to stimulation,
and diarrhea they were euthanized in an effort to minimize their
pain and distress.
Western Blots
Spinal cords from wild type and knockout mice (as determined
by PCR genotyping) were dounce homogenized in PBS containing
protease inhibitors, then sonicated. Lysates were centrifuged at
20,000 g for 30 minutes at 4uC. Protein concentrations were
determined by Bradford Assay and normalized. After adding
loading dye, proteins were separated by SDS-PAGE, then
transferred to a PVDF membrane for 90 minutes at 50 V. The
membrane was blocked in Blocking Buffer (Rockland), then
incubated at room temperature with PREPL primary antibody
(Polyclonal PREPL antibody was generated by Open Biosystems
in rabbits using a peptide epitope (EELGLDSTDAFEALK-
KYLKF) derived from murine PREPL) overnight at 4uC. The
membrane was then washed 36with TBS-T for 5 minutes each,
followed by incubation with secondary antibody (IRDye 680LT
Donkey Anti-Rabbit (LICOR)) at room temperature for one hour.
After washing 36, the western blot was imaged on a LICOR
Odyssey imager.
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RT-PCR
To determine levels of Prepl transcripts in liver, RT-PCR was
performed. For Prepl, the QT00143689 primer set (Qiagen), which
amplifies a 113-bp amplicon covering parts of exons 6 and 7, was
used. GAPDH was used as a reference gene, with the following
primers: GAPDHfwd CTC CAC TCA CGG CAA ATT CA,
GAPDHrev ATG GGC TTC CCG TTG ATG A [27]. Livers
from Prepl2/2 and Prepl+/+ mice (as determined by PCR
genotyping) were harvested and snap frozen in liquid nitrogen.
RNA was extracted using the RNeasy kit (Qiagen), with the
following adaptations: a small piece of liver was Dounce
homogenized in 600 mL of the RLT buffer (10 mL b-mercapto-
ethanol added per mL), then passed through a 21-gauge needle 10
times on ice. After this, the protocol in the RNeasy kit was
followed. RNA concentrations were determined by Nanodrop
(Thermo Scientific) and normalized to 100 ng/mL. RNA integrity
was assessed by agarose gel. Genomic DNA removal and reverse
transcription were performed with the QuantiTect Reverse
Transcription Kit (Qiagen) according to the manufacturer’s
instructions. PCR was carried out using the Quantitect SYBR
Green PCR Kit according to the manufacturer’s instructions. No
template control wells were included and ROX was used a
reference dye. The MX3000p thermocycler (Stratagene) was used,
with the first segment comprising 15 minutes at 95uC, the second
segment comprising 30 sec at 95uC, 1 min at 55uC, 1 min at 72uC
for 40 cycles, and the third and final segment comprising 1 min at
95uC, 30 sec at 50uC, 30 sec at 99uC. Relative concentrations of
Prepl mRNA was determined using the formula 100*2(Ct(PREPL)-
Ct(GAPDH), where Ct(PREPL) or Ct(GAPDH) is the average cycle
threshold for 3 technical replicates with a given sample and primer
set.
Growth Curves
Prepl2/2 and Prepl+/+ mice were sexed and weighed every day
from the day of birth until postnatal day 40. They were weaned at
day 21. Beyond P40, mice were weighed every week to obtain
long-term growth curves.
Grip Strength
To measure grip strength, we used the Chatillon Grip Strength
Meter to measure forelimb grip strength. The grip strength meter
was set to T-PK to measure the maximum force exerted as mice
were gripped by the tail, allowed to grab onto the grid with both
forelimbs, then gently pulled away with a constant speed until the
grasp is broken. The measurement was repeated five times for
each animal, with a one minute break between measurements.
The average maximum force over the five trials was calculated for
each mouse and normalized to the weight of the mouse. The
animals tested were 6 month old females, not backcrossed and
their genotypes had been determined by PCR genotyping.
Righting Task
Young pups (5–6 days), were placed on their backs on a clean
and flat surface, and the time required for them to assume their
normal upright posture with all four paws on the ground was
measured.
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